Photothermal Hyperthermia Suppresses Liver Tumor Growth Via Hippo Signaling Pathway-Dependent Inhibition of Cell Proliferation and Induction of Apoptosis
Open Access
- 17 June 2025
- journal article
- research article
- Published by Springer Nature in Biological Procedures Online
- Vol. 27 (1) , 1-13
Abstract
Hepatocellular carcinoma (HCC) ranks as the third most common malignant tumor globally. Although hyperthermia has shown promise as a non-invasive treatment for tumors, its specific mechanisms and impact on HCC remain underexplored. This study aims to investigate the effects of hyperthermia on HCC proliferation and apoptosis and to elucidate the role of the Hippo signaling pathway in these processes. Huh7 and HepG2 HCC cells were cultured at various temperatures (37 °C, 40 °C, 43 °C, and 46 °C), with 37 °C as the control. Cell proliferation, apoptosis, and cell cycle distribution were assessed via CCK-8 assays and flow cytometry. A subcutaneous xenograft model in nude mice, treated with indocyanine green (ICG) and near-infrared (NIR) irradiation to achieve local hyperthermia, was used to evaluate in vivo tumor growth. RNA-seq and KEGG pathway analyses identified differentially expressed genes, and Western blotting and immunofluorescence were used to confirm the involvement of the Hippo signaling pathway. Hyperthermia at 43 °C significantly inhibited Huh7 and HepG2 cell proliferation and induced apoptosis, accompanied by cell cycle arrest. In vivo, local hyperthermia reduced tumor volume and weight in the ICG + NIR-treated group. RNA-seq and KEGG analyses revealed that the Hippo signaling pathway was activated under hyperthermic conditions, with YAP expression and nuclear translocation markedly downregulated. Further experiments showed that YAP overexpression mitigated hyperthermia-induced effects on cell proliferation and apoptosis, underscoring the role of the Hippo pathway. These findings demonstrate that hyperthermia inhibits HCC growth by regulating the Hippo signaling pathway, reducing cell proliferation, and promoting apoptosis. This study highlights the potential of hyperthermia as an effective therapeutic approach for HCC, with implications for developing targeted hyperthermic therapies.Keywords
Funding Information
- the Key Research and Development Project of Henan Province (231111311300)
- the Technological Projects of Henan Province (232102310070)
- the Key Scientific Research Projects of Universities in Henan Province (24A310013)
- the Joint Fund of the Henan Science and Technology Research and Development Program (245101610006)
This publication has 40 references indexed in Scilit:
- YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to TherapyBioEssays, 2020
- Principles and applications of nanomaterial-based hyperthermia in cancer therapyArchives of Pharmacal Research, 2020
- Role of the transcriptional coactivators YAP/TAZ in liver cancerCurrent Opinion in Cell Biology, 2019
- Whole-body hyperthermia in combination with systemic therapy in advanced solid malignanciesCritical Reviews in Oncology/Hematology, 2019
- A Model for the Hippo Pathway in the Drosophila Wing DiscBiophysical Journal, 2018
- Therapeutic hyperthermia: The old, the new, and the upcomingCritical Reviews in Oncology/Hematology, 2016
- Indocyanine green angiography-guided management of Vogt–Koyanagi–Harada disease: differentiation between choroidal scars and active lesionsInternational Ophthalmology, 2013
- Hepatitis B virus X protein modulates oncogene yes-associated protein by CREB to promote growth of hepatoma cellsHepatology, 2012
- Hyperthermia induces translocation of apoptosis-inducing factor (AIF) and apoptosis in human glioma cell linesJournal of Neuro-Oncology, 2004
- Hyperthermia in combined treatment of cancerThe Lancet Oncology, 2002